Kin Health raises $9M for AI-powered patient notetaker

The market for AI-powered notetaking tools in the U.S. has surged past $600 million in revenue, driven largely by healthcare applications. Startups like Heidi Health and Freed have capitalized on this demand, offering doctors a way to track patient conversations, access health records, and reduce administrative strain. However, these solutions largely ignore the patient’s perspective. That gap is exactly what Kin Health aims to fill.

Kin Health has secured $9 million in seed funding, led by Maveron, to build an AI notetaker designed specifically for patients. The app records doctor visits and generates a clear, actionable summary of the meeting, including next steps. Users can share these summaries with family or friends, and they can also jot down questions for future appointments. All data is encrypted and kept private by default, the company says. While Kin Health is not HIPAA-certified because it is a patient-facing tool, it follows the same privacy standards.

The free app was created by physicians Arpan and Amit Parikh, alongside Kyle Alwyn, who previously founded online prescription service HeyDoctor and sold it to GoodRx. GoodRx co-founders Doug Hirsch and Trevor Bezdek serve as founding partners and executive chairmen. Alwyn explained the vision: “We have a lot of storage cabinets where our health data can live, but we don’t have a way to convert that into a utility that we can use to drive our behavioral change. Our goal is to create this health graph where we can store your information from multiple different sources.”

Kin Health processes summaries in stages. The app first transcribes the visit, then converts that transcription into a clinical narrative, and finally distills it into a patient-friendly summary with action items. The company relies on specialized medical models for transcription and monitors outputs at each stage to ensure accuracy.

Yet AI in healthcare remains a cautious space. Privacy experts and researchers have flagged concerns about data security, AI accuracy, consent, and the quality of generated notes. Regional accents also pose a challenge for many AI notetakers. Kin Health says it is actively working to handle different accents, as well as speech affected by a sore throat or a mask.

Dr. Rebecca Mishuris, chief health information officer at Mass General Brigham, stressed the importance of clinician oversight. “Generative AI will hallucinate; that is the nature of a technology built on patterns and prediction. That is why it is so important for clinicians to review the drafted notes before signing them. At the end of the day, the responsibility for the documentation falls to the clinician,” she said.

Currently, Kin Health only processes notes from its own recorded conversations. But the company plans to integrate data from other sources this year, including physician notes from electronic health record (EHR) systems. The app will remain free forever, monetizing through referrals to specialists, labs, and other services. This model mirrors GoodRx’s approach, where the core product is free and revenue comes from commissions on referrals.

Natalie Dillion, a partner at Maveron, highlighted the strategic advantage. “Healthcare provider-side tools often expect patients to coordinate their own treatment actions. Kin is built to solve an entirely different consumer need: it can travel with them between specialists, systems, and providers. It’s not beholden to any single health network or EHR relationship. It’s built to serve the patient, not the institution, and that’s a massive distribution advantage.”

The seed round also included Town Hall Ventures, Eniac Ventures, Flex Capital, Foundry Square Capital, Pear VC, The Family Fund, GoodRx’s Hirsch and Bezdek, angel investors Jay Desai, Nabeel Quryshi, Alex Cohen, Saharsh Patel, and more than 30 physicians.